CBLB and type 1 diabetes mellitus: Transgenic complementation with wild type CBLB greatly suppresses the development of the Komeda diabetes-prone phenotype, indicating that CBLB is a negative regulator of autoimmunity and a susceptibility gene for T1DM in the rat [42].